Your TL;DR
Rejection in SBIR/STTR is common, and resubmission is still possible, but the structure has tightened. NIH allows one formal resubmission, while NSF and DoD treat revised proposals as new submissions. The advantage does not come from trying again, it comes from correcting how reviewers interpreted risk, feasibility, and alignment the first time.
Rejection Is Common, but the Path Forward Is Different Than It Used to Be
An SBIR or STTR rejection is rarely the end of the road. It is often the first real signal of how reviewers are interpreting your work. What has changed is how agencies structure second attempts.
NIH allows a single formal resubmission. After that, any future attempt must be submitted as a new application. NSF and the Department of War (DoW) do not use a formal resubmission label at all. Applicants revise and submit again into a future cycle, and the proposal is evaluated as new.
The opportunity to try again still exists across all agencies. The constraint is that each attempt must stand on its own, with clearer alignment to how the agency evaluates feasibility, risk, and potential impact.
If you are deciding whether to revise and submit again, EBHC can provide perspective on how reviewer feedback translates into scoring changes before you commit to another cycle.
What Reviewer Feedback Actually Tells You
Feedback is often treated as a checklist of edits. In practice, it is a map of how reviewers perceived risk.
Comments about unclear aims, weak commercialization, or unrealistic timelines are rarely isolated issues. They usually point to a deeper concern that the project is not yet executable within the structure of the program.
Strong resubmissions do not simply answer reviewer comments. They correct the underlying logic that produced those comments in the first place.
Where Most Resubmissions Fall Short
The gap appears when teams revise language without revising structure.
It is common to see resubmissions that:
- Add more detail without clarifying the technical path
- Expand commercialization sections without strengthening evidence
- Adjust wording without tightening scope or milestones
These changes improve readability but do not change how the proposal is scored.
Reviewers are not looking for more content. They are looking for signals that the project can be executed as proposed, within budget and within the expectations of the agency.
Why a Revised Proposal Can Be More Competitive
A strong resubmission reflects a different level of control.
Objectives connect more directly to tasks.
Budgets align with defined outputs.
Commercialization narratives are grounded in validation, not projection.
These shifts signal that the team understands not just the problem they are solving, but how the agency evaluates whether that solution is worth funding.
That is what changes outcomes between cycles.
Aligning with Agency Expectations Before You Resubmit
Each agency interprets merit differently. NIH evaluates clinical or health relevance alongside feasibility. NSF emphasizes technical innovation and broader impact. The DoW focuses on mission alignment and transition pathways.
A resubmission is an opportunity to recalibrate against those expectations.
This often means revisiting:
- How technical risk is defined and mitigated
- Whether the work plan reflects Phase I feasibility rather than Phase II ambition
- How commercialization or transition is framed based on agency priorities
Teams that make these adjustments early tend to avoid repeating the same reviewer concerns.
Treating Resubmission as a New Submission
Even when a proposal is formally labeled as a resubmission, it is effectively judged as a new application.
Reviewers may or may not be the same. Context may shift. Program priorities may evolve between cycles.
The strongest approach is to treat the next submission as a fresh case for funding, not a defense of the previous one.
If you are preparing to resubmit, consider whether your revised proposal would stand on its own without the context of prior reviewer comments. That question often reveals whether the core issues have been resolved.
From Revision to Repositioning
Resubmission is not about persistence alone. It is about repositioning the proposal so that it aligns with how agencies interpret risk, feasibility, and impact.
That shift is where most of the value sits.
If you want a second set of eyes on whether your revised proposal addresses the right issues, EBHC can review how your changes map to what reviewers actually score.
Conclusion
Resubmissions remain a viable path in SBIR and STTR, but they are more constrained and more demanding than many applicants expect. The advantage does not come from submitting again. It comes from understanding why the proposal was not funded and making changes that alter how it is evaluated.
Ready To Take the Next Step?
We assist our clients in locating, applying for, and evaluating the outcomes of non-dilutive grant funding. We believe non-dilutive funding is a crucial tool for mitigating investment risks, and we are dedicated to guiding our clients through the entire process—from identifying the most suitable opportunities to submitting and managing grant applications.